stars 1 stars 2 stars 3

Intendis is a specialized pharmaceutical company focused on the Dermatologicals category. Headquartered in Berlin, Germany the company was founded in 2005 as a subsidiary of Schering AG. Intendis has a successful track record of providing prescription drug products for the treatment of severe skin diseases and was a pioneer in the development of locally applicable corticosteroid treatments.

Intendis Questions

The Intendis annual revenue was $5 million in 2026.

Gary Tighe is the Vice President Sales and Managed Markets of Intendis.

13 people are employed at Intendis.

The NAICS codes for Intendis are [325, 3254, 32541, 32].

The SIC codes for Intendis are [2834, 28, 283].

Top Intendis Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users